WINTON GROUP Ltd - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,424,000
+35.2%
8,274
-1.4%
0.08%
+40.4%
Q2 2021$1,053,000
-26.1%
8,389
-20.1%
0.06%
-29.6%
Q1 2021$1,424,000
+72.8%
10,503
+63.1%
0.08%
+37.3%
Q4 2020$824,000
-58.7%
6,441
-63.6%
0.06%
-9.2%
Q3 2020$1,994,000
-34.1%
17,718
-44.2%
0.06%
-16.7%
Q2 2020$3,024,000
+102.7%
31,737
+91.2%
0.08%
+100.0%
Q1 2020$1,492,000
+69.0%
16,599
-0.3%
0.04%
+225.0%
Q4 2019$883,00016,6510.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders